Save 20% on Press Releases and More with NNW Prime! Click to View Details
FridayMar 03, 2017 11:18 am

NetworkNewsBreaks – Achaogen, Inc. (NASDAQ: AKAO) Provides Updates on Drug Candidates During R&D Day

Achaogen (NASDAQ: AKAO) recently held a research and development (R&D) day to provide an overview of its programs. The meeting included presentations from members of Achaogen’s leadership team and medical community key opinion leaders. During the day, the company discussed C-Scape, its new orally administered antibacterial candidate to treat patients with complicated urinary tract infections. Achaogen plans to begin a clinical trial of C-Scape in 2017. Additionally, the R&D day provided an overview of the plazomicin program, including a review of the positive phase 3 results, progress toward the planned New Drug Application (NDA) submission and preparation for commercialization. The…

Continue Reading

FridayMar 03, 2017 11:15 am

NetworkNewsBreaks – aTyr Pharma, Inc. (NASDAQ: LIFE) Receives EMA Orphan Drug Designation for Resolaris™; Shares Pull from Early Gains

Reversing from a pre-market spike, shares of aTyr Pharma (NASDAQ: LIFE) are down 4% on word that the company’s Resolaris™ has received Orphan Drug Designation from the European Medicines Agency (EMA) for the treatment of limb girdle muscular dystrophy (LGMD) patients. Orphan designation was advised following a positive opinion by the EMA's Committee for Orphan Medicinal Products. Medicines that receive the designation are eligible for various incentives, including assistance with development of the medicine; reduced fees for marketing-authorization applications; and extended market exclusivity once the medicine is authorized. The company also received Orphan Drug Designation from the U.S. FDA earlier…

Continue Reading

ThursdayMar 02, 2017 1:22 pm

NetworkNewsBreaks – ORHub, Inc. (ORHB) Collaborates with Microsoft (NASDAQ: MSFT) on Solution to Alleviate Costly Aspect of Health Care

ORHub (OTC: ORHB) today introduced a new solution, built on Microsoft’s (NASDAQ: MSFT) Azure enterprise-grade cloud computing platform, that focuses on the single biggest cost center for health care: surgery. The company has created a value-based solution that tracks the cost of treating a condition from diagnosis to discharge, as well as outcomes that resulted from that treatment. This results in decreases in cost and improvement in outcomes by eliminating inefficiencies, duplication of effort, and errors and omissions. The company worked with Microsoft for Startups on a variety of technical engagements that helped create the digital platform's initial architecture. The…

Continue Reading

ThursdayMar 02, 2017 12:35 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on March 2, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: ALQA 27.11% – News: Presenting at Cowen and Company 37th Annual Health Care Conference on March 8 VBIO 19.65% – News: Develops proprietary THC pharmaceutical with reduced psychoactivity RNVA 16.36% – News: Big South Fork Medical Center receives nearly 200 job applications through online portal BKIT 13.85% – News: Presents clinical trial team INFI 12.33% – News: Presenting IPI-549 data at AACR Annual Meeting DYAI 12.00% – News: Reaches settlement with the last law…

Continue Reading

ThursdayMar 02, 2017 12:32 pm

NetworkNewsBreaks – Bridgeline Digital, Inc. (NASDAQ: BLIN) Secures Three-Year Deal with Top Regional Medical Group for iAPPS Platform

Bridgeline Digital (NASDAQ: BLIN) this morning announced that a top regional multi-specialty medical group has chosen Bridgeline’s iAPPS Platform to power its online portal and marketing automation. The medical group has agreed to a three-year SaaS subscription to iAPPS Experience Manager Pro, Bridgeline’s comprehensive experience management suite. The platform includes web content management and digital marketing automation, as well as associated professional services. Additionally, the company will develop a custom online portal for the medical group’s multiple locations. “Experience Manager Pro provides the optimal blend of features to manage website content which engages existing patients while in parallel driving new…

Continue Reading

ThursdayMar 02, 2017 11:50 am

NetworkNewsBreaks – Tonix (NASDAQ: TNXP) Reports Successful Synthesis of Pre-Clinical Smallpox-Preventing Vaccine Candidate TNX-801

Shares of Tonix Pharmaceuticals Holding (NASDAQ: TNXP) gained 4% this morning as the company, along with researchers from the University of Alberta, announced the successful synthesis of a potential smallpox-preventing vaccine. The vaccine candidate, TNX-801, is a live form of horsepox virus (HPXV) that has demonstrated protective vaccine activity in mice. HPXV was synthesized at the University of Alberta, with Dr. Lederman as co-investigator of the research and co-inventor of the TNX-801 patent. Per the research and development agreement, Tonix wholly owns the synthesized HPXV virus stock and related sequences. Tonix has initiated vaccine manufacturing activities to support further nonclinical…

Continue Reading

ThursdayMar 02, 2017 11:47 am

NetworkNewsBreaks – Innovus Pharma (INNV) Receives Receipt of Notification to Commercialize Zestra® in the EU; Shares Rise

Innovus Pharmaceuticals (OTCQB: INNV) shares are higher this morning after the company said that it received the CPNP notification number required to commercialize Zestra® in all 28 member countries of the European Union. The over-the-counter consumer goods and specialty pharmaceutical company is engaged in commercialization, licensing and development of safe and effective non-prescription medicine. In addition to the largest market for Zestra®, the United States, Innovus Pharma currently generates Zestra® revenues from markets in Canada, Morocco, certain European countries and Hong Kong. “We are pleased to expand the commercialization market for Zestra® to the second largest market in the world…

Continue Reading

ThursdayMar 02, 2017 11:44 am

NetworkNewsBreaks – ProBility Media Corp. (PBYA) Announces Collaboration to Provide Employment for Adults with Disabilities; Shares Spike 13%

Shares of ProBility Media Corp. (OTCQB: PBYA) are up 13% mid-morning after the company announced a new initiative with MainStreet Opportunities and Celebration Company of Jewish Family Services. MainStreet Opportunities is an employment program that helps adults with disabilities find and uphold employment, while Celebration Company is a transitional employment program for adults living with disabilities. ProBility’s wholly-owned subsidiary, One Exam Prep, has implemented an optional service to its line of study materials, now offering study materials with highlights and tabs, making it easier to review and study the exam preparation materials. Under the new initiative, One Exam Prep will…

Continue Reading

ThursdayMar 02, 2017 11:40 am

NetworkNewsBreaks – CFN Media Examines Singlepoint’s (SING) “Low-Risk Approach to the Cannabis Industry” in New Article

Earlier today, Singlepoint, Inc. (OTC: SING) was revealed as the focus of an article (http://nnw.fm/VKmu4) published by CFN Media Group, a creative agency and digital media network dedicated to the legal cannabis industry. More specifically, the CFN article focuses on recent comments by White House Press Secretary Sean Spicer regarding the enforcement of federal cannabis regulations, as well as what those regulations could mean for Singlepoint’s operations in the cannabis space. “Singlepoint has stepped in to address some of these industry challenges with its own solutions in a way that doesn't involve touching the drug at all,” the article notes.…

Continue Reading

ThursdayMar 02, 2017 10:17 am

NetworkNewsBreaks – Stealth Technologies, Inc. (STTH) Announces Completion of Five New Products

Security and personal protection company Stealth Technologies, Inc. (OTCQB: STTH) this morning announced the completion of five new products that are now awaiting market rollout. The products are currently undergoing final review by a large direct response retailer’s quality assurance and legal department in order to ensure that the marketing claims associated with each product are accurate when compared to actual performance levels. This ongoing review will also ensure that the company’s existing inventory meets all necessary quality control parameters. “The new products range from consumer electronics to additional security and safety products,” Brian McFadden, CEO of Stealth Technologies, stated…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000